Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-like protein Rib is a surface-anchored protein found in Streptococcus agalactiae (Group B Streptococcus, GBS), primarily associated with serotype III strains that cause invasive neonatal disease [1, 3]. It is a member of the Alpha-like protein (Alp) family and is characterized by a large number of identical tandem repeats that are highly immunogenic [3, 4]. Rib functions as a virulence factor by promoting bacterial adhesion to host epithelial cells and facilitating immune evasion, thereby contributing to the development of neonatal sepsis and meningitis [3]. Due to its high prevalence in clinical isolates and its ability to elicit protective opsonophagocytic antibodies, Rib is a key component in several multivalent GBS vaccine candidates, such as Pfizer's GBS6 [2]. Therapeutic strategies focusing on Rib aim to provide passive or active immunity to prevent maternal colonization and subsequent vertical transmission to newborns [2, 4].
Induction of opsonophagocytic antibodies that facilitate bacterial clearance and prevent host cell invasion.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-like protein Rib (Rib).